The Board of Directors of Diamyd Medical has appointed Anders Essen-Möller as new Chairman of the Board.
Former Chairman Erik Nerpin was appointed Vice Chairman.
“Anders Essen-Möller’s importance to Diamyd Medical as founder, former CEO, Board member and not least as an investor, together with his significant experience, can hardly be overestimated,” says Erik Nerpin, Vice Chairman of Diamyd Medical. “It therefore feels natural that we now make this change.”
Clarify Anders Essen-Möller’s significant role in the company
The purpose of the rockade within the Board of Directors is to clarify Anders Essen-Möller’s significant role in the company, the company states. Anders Essen-Möller will continue his consulting assignment for Diamyd Medical and thus become Executive Chairman of the Board.
Anders Essen-Möller founded Diamyd Medical and was previously CEO and later Chairman of the Board until 2015.”
Anders Essen-Möller founded Diamyd Medical and was previously CEO and later Chairman of the Board until 2015. Erik Nerpin then took over the role as Chairman of the Board when Anders Essen-Möller for a period re-entered as CEO of the Company before current CEO Ulf Hannelius took office in April 2016.
“We have worked closely together for several years, and we look forward to together maximizing the opportunities we see in the company,” says CEO Ulf Hannelius and Chairman Anders Essen-Möller in a joint statement.
Photo of Anders Essen-Möller: Diamyd.com
